# Pfizer - Research Sources

**Generated:** 2025-12-09 00:10

*All sources used in this research report*

---

## Primary Sources

### Query: *Pfizer revenue 2024*

1. **[Pfizer Reports Strong Q4 and Full-Year 2024 Results](https://insights.pfizer.com/fourth-quarter-fy-earnings-2024)** *(serper)*
   > Full-year 2024 revenues were $63.6 billion, representing 7% year-over-year operational growth, while fourth-quarter revenues were $17.8 billion, ...

2. **[[PDF] Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 ...](https://s206.q4cdn.com/795948973/files/doc_financials/2024/q4/Q4-2024-PFE-Earnings-Release-Final.pdf)** *(serper)*
   > Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion, or 22%, compared to the prior-year quarter, reflecting an ...

3. **[Pfizer revenue 2006-2024 - Statista](https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/?srsltid=AfmBOop8hEEYPCuIpQhmg1HgEtAlfqEMNL47dP8lw9kFyTlgSCWihkke)** *(serper)*
   > In 2024, Pfizer reported revenues totaling more than 63 billion U.S. dollars.

4. **[Pfizer Revenue 2011-2025 | PFE - Macrotrends](https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue)** *(serper)*
   > Pfizer annual revenue for 2024 was $63.627B, a 6.84% increase from 2023. Pfizer annual revenue for 2023 was $59.553B, a 41.14% decline from 2022.

5. **[Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year ...](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-provides-full-year-2025-guidance-and-reaffirms-full)** *(serper)*
   > Pfizer anticipates full-year 2025 revenues to be in the range of $61.0 to $64.0 billion, which includes the expectation of revenues from our COVID-19 products ...


### Query: *Pfizer post-COVID portfolio*

6. **[New Drug Development Pipeline - Pfizer](https://www.pfizer.com/science/drug-product-pipeline)** *(serper)*
   > Explore the Product Pipeline. Take a deep dive into the investigational medicines and vaccines we're working on. Updated as of November 4, 2025.

7. **[Why Pfizer's Post-COVID Future Looks Brighter Than Ever](https://finance.yahoo.com/news/why-pfizers-post-covid-future-172800014.html)** *(serper)*
   > A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

8. **[Why Pfizer's Post-COVID Future Looks Brighter Than Ever](https://www.fool.com/investing/2025/09/28/why-pfizers-post-covid-future-looks-brighter-than/)** *(serper)*
   > A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

9. **[Pfizer's CFO on building a post-Covid future and how it won the fight ...](https://sherwood.news/markets/pfizers-cfo-on-building-a-post-covid-future-and-how-it-won-the-fight-for/)** *(serper)*
   > It's a portfolio of mid- and early-stage obesity assets — both GLP-1s and amylins — and potentially combinations of both. There are three ...

10. **[Our portfolio | Pfizer](https://www.pfizer.com/partners/venture-investments/our-portfolio)** *(serper)*
   > BioNTech leverages its deep immunology expertise and experience to develop and optimize mRNA therapeutics for serious diseases such as cancer, COVID-19, malaria ...


### Query: *Pfizer Seagen acquisition*

11. **[Pfizer Completes Acquisition of Seagen](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen)** *(serper)*
   > Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 ...

12. **[Pfizer Invests $43 Billion to Battle Cancer](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-invests-43-billion-battle-cancer)** *(serper)*
   > Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion · Proposed combination ...

13. **[Pfizer's $43B buyout of ADC specialist Seagen is a done deal](https://www.fiercepharma.com/pharma/done-deal-pfizer-completes-43b-acquisition-seagen-doubling-its-oncology-pipeline)** *(serper)*
   > Pfizer's $43 billion acquisition of Seagen is in the books, the company said on Thursday, as it becomes the largest M&A transaction in the biopharma industry.

14. **[Pfizer gets OK for $43-billion Seagen deal after donating cancer ...](https://www.reuters.com/markets/deals/pfizer-gets-ok-43-bln-seagen-deal-after-donating-cancer-drug-rights-2023-12-12/)** *(serper)*
   > Pfizer said on Tuesday it expects to close its $43 billion deal to buy cancer drugmaker Seagen later this week and plans to create a new ...

15. **[Pfizer Completes $43 Billion Acquisition of Seagen - FTI Consulting](https://www.fticonsulting.com/insights/success-stories/pfizer-completes-43-billion-acquisition-seagen)** *(serper)*
   > on December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen — the largest M&A deal in biopharma since 2019 ...


### Query: *Pfizer oncology pipeline*

16. **[Oncology: Cancer Drug Pipeline and Clinical Trials - Pfizer](https://www.pfizer.com/science/oncology-cancer/pipeline)** *(serper)*
   > Our strong pipeline—one of the most robust in the industry—includes biologics, small molecules, immunotherapies, and biosimilars ...

17. **[New Drug Development Pipeline - Pfizer](https://www.pfizer.com/science/drug-product-pipeline)** *(serper)*
   > Explore the Product Pipeline. Take a deep dive into the investigational medicines and vaccines we're working on. Updated as of November 4, 2025.

18. **[Overview - by Cancer | Pfizer Oncology Development Website](https://www.pfizeroncologydevelopment.com/)** *(serper)*
   > Breast Cancer · Tegtociclib (PF-07104091) + Atirmociclib (PF-07220060) · Vepdegestrant (ARV-471)* + Atirmociclib (PF-07220060) · Atirmociclib (PF-07220060).

19. **[[PDF] 1 - Pfizer Pipeline](https://cdn.pfizer.com/pfizercom/product-pipeline/Pipeline_Update_04FEB2025.pdf?VersionId=uLH0GvYiQQ5ovLs6eCxf0ZluTI3FZh_f)** *(serper)*
   > Pfizer announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal ...

20. **[Explore Our Cancer (Oncology) Clinical Trials | Pfizer](https://www.pfizerclinicaltrials.com/our-research/oncology)** *(serper)*
   > Pfizer has clinical trials for adults and children in over 20 cancer types. Select from the list below to view clinical trials that are looking for ...


### Query: *Pfizer vs Merck pharma*

21. **[What Investors Are Missing about Pfizer and Merck | Yale Insights](https://insights.som.yale.edu/insights/what-investors-are-missing-about-pfizer-and-merck)** *(serper)*
   > Pfizer's pharma pipeline is underappreciated outside the labs. With yet another quarter where Pfizer handily beat consensus earnings ...

22. **[PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?](https://www.nasdaq.com/articles/pfe-vs-mrk-which-oncology-drug-giant-better-buy-now)** *(serper)*
   > Both MRK and PFE are priced lower than the industry from a valuation standpoint. MRK is more expensive than PFE, going by the price/earnings ...

23. **[Better High-Yield Dividend Stock: Pfizer vs. Merck | The Motley Fool](https://www.fool.com/investing/2025/02/10/better-high-yield-dividend-stock-pfizer-vs-merck/)** *(serper)*
   > At recent prices, you can buy shares of Merck (MRK 1.16%) that offer a yield above 3%, and shares of Pfizer (PFE +1.28%) offer a yield above 6%.

24. **[Merck vs. Pfizer: The Big Pharma Showdown - Juristat Blog](https://blog.juristat.com/merck-vs-pfizer)** *(serper)*
   > The most dramatic difference is between allowance rates, with Merck having an allowance rate 20 percentage points higher than Pfizer.

25. **[Which is the Healthiest Investment: Merck or Pfizer | FAST Graphs](https://www.youtube.com/watch?v=qS0qI1jZ8vI)** *(serper)*
   > Valuation, is going to take a deep dive into Merck (MRK) and Pfizer (PFE), two of the biggest pharmaceutical companies out there. Chuck is ...


### Query: *Pfizer earnings 2024*

26. **[Pfizer 2024 Annual Report: Pfizer's year in review](https://annualreview.pfizer.com/)** *(serper)*
   > For full-year 2024, we reported total revenues of $63.6 billion, reflecting 7% year-over-year operational growth. Our operational revenue growth when excluding ...

27. **[[PDF] Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 ...](https://s206.q4cdn.com/795948973/files/doc_financials/2024/q4/Q4-2024-PFE-Earnings-Release-Final.pdf)** *(serper)*
   > Fourth-quarter 2024 revenues totaled $17.8 billion, an increase of $3.2 billion, or 22%, compared to the prior-year quarter, reflecting an ...

28. **[Pfizer Quarterly Corporate Performance - Fourth Quarter 2024](https://investors.pfizer.com/Investors/Events--Presentations/event-details/2025/Pfizer-Quarterly-Corporate-Performance---Fourth-Quarter-2024-2025-bJsrFv43x5/default.aspx)** *(serper)*
   > Quarterly results, annual reports, SEC filings, news, stock info, stock quote, stock chart, historical stock quote, investment calculator, dividend & split ...

29. **[Pfizer Delivers Strong Third-Quarter 2024 Financial Results and ...](https://insights.pfizer.com/q324earnings)** *(serper)*
   > The company reported revenues of $17.7 billion in the third quarter, representing 32% year-over-year operational growth. Excluding the company's ...

30. **[Pfizer (PFE) earnings Q4 2024 - CNBC](https://www.cnbc.com/2025/02/04/pfizer-pfe-earnings-q4-2024.html)** *(serper)*
   > The company booked fourth-quarter net income of $410 million, or 7 cents per share. That compares with a net loss of $3.37 billion, or a loss of ...


---

## Source Statistics

- **Total Sources**: 40
- **Unique Queries**: 6
- **Research Date**: 2025-12-09

### Source Providers
- **serper**: 40 sources

---

*This is part of the Pfizer research report. See [Full Report](00_full_report.md) for complete analysis.*
